Lundbeck upgrades annual earnings guidance, cuts revenue outlook

Revenue will end up in the lower end of the spread Lundbeck forecast in early 2021, the Danish pharmaceutical firm informs after closing the first two quarters of this year.
Photo: Jens Dresling
Photo: Jens Dresling

After making it through the first half of 2021, Lundbeck adjusts its annual financial guidance, which was set rather wide in the beginning of the year. Now the group makes both upward and downward adjustments.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading